Documentos relacionados

1. Tn-syndrome.
2. Toll-like receptor signaling in hematopoietic stem and progenitor cells.
3. Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis.
4. Immune-Mediated Cytopenias After Hematopoietic Cell Transplantation: Pathophysiology, Clinical Manifestations, Diagnosis, and Treatment Strategies.
5. Natural killer cell licensing after double cord blood transplantation is driven by the self-HLA class I molecules from the dominant cord blood.
6. Mechanical hemolysis: A low mean cell volume does not always represent microcytosis.
7. Extramedullary hematopoiesis in unusual locations in hematologically compromised and noncompromised patients.
8. Of drills and bones: Giovanni Ghedini and the origin of bone marrow biopsy.
9. Specificity of drug-induced immune cytopenias.
10. Clinical Implications of Single-Cell Microfluidic Devices for Hematological Disorders.